☆ 4.7 Article

Neutralization Assessments Reveal High Cardiothoracic Ratio and Old Age as Independent Predictors of Low Neutralizing Antibody Titers in Hemodialysis Patients Receiving a Single Dose of COVID-19 Vaccine

JOURNAL OF PERSONALIZED MEDICINE (2022)

Related references

Note: Only part of the references are listed.

Letter Urology & Nephrology

COVID-19 Vaccine Type and Humoral Immune Response in Patients Receiving Dialysis

Pablo Garcia et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2022)

Add to Collection

Article Immunology

The Effectiveness of the Two-Dose BNT162b2 Vaccine: Analysis of Real-World Data

Gabriel Chodick et al.

Summary: The study evaluated the real-world effectiveness of the BNT162b2 vaccine in Israel, showing a significantly reduced incidence of infection during the protection period compared to the reference period. The vaccine demonstrated 90% effectiveness in preventing infection and 94% effectiveness against COVID-19, with lower efficacy observed in immunosuppressed elderly individuals.

CLINICAL INFECTIOUS DISEASES (2022)

Add to Collection

Article Immunology

Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccines for Preventing Coronavirus Disease 2019 Hospitalizations in the United States

Mark W. Tenforde et al.

Summary: From March to May 2021, full vaccination using authorized mRNA products was associated with 87.1% protection against COVID-19 hospitalization among US adults, with lower effectiveness in adults with immunosuppression compared to those without. Vaccination was beneficial for patients with immunosuppression, but the effectiveness was lower in this population.

CLINICAL INFECTIOUS DISEASES (2022)

Add to Collection

Editorial Material Transplantation

At least 156 reasons to prioritize COVID-19 vaccination in patients receiving in-centre haemodialysis

Christian Combe et al.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2021)

Add to Collection

Review Multidisciplinary Sciences

The chronic kidney disease and acute kidney injury involvement in COVID-19 pandemic: A systematic review and meta-analysis

Ya-Fei Liu et al.

Summary: The study indicates that patients with severe COVID-19 are more likely to have chronic kidney disease (CKD) and complications of acute kidney injury (AKI). Continuous renal replacement therapy (CRRT) is more frequently used in severe patients, and the risk of AKI is higher in the critical group.

PLOS ONE (2021)

Add to Collection

Editorial Material Urology & Nephrology

The urgent need to vaccinate dialysis patients against severe acute respiratory syndrome coronavirus 2: a call to action

Anna Francis et al.

KIDNEY INTERNATIONAL (2021)

Add to Collection

Article Medicine, General & Internal

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

Merryn Voysey et al.

Summary: The AZD1222 vaccine has been approved for emergency use in the UK with an interval of 4-12 weeks between doses. Analysis shows that the vaccine is efficacious with two doses and provides immunoprotection after the first dose before the second dose is administered.

LANCET (2021)

Add to Collection

Letter Medicine, General & Internal

Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients

Brian J. Boyarsky et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Add to Collection

Article Immunology

Overview of Neutralizing Antibodies and Their Potential in COVID-19

Jose Javier Morales-Nunez et al.

Summary: This review article discusses the essential concepts of NAbs, including their mechanisms of action, production, and detection techniques, as well as providing an overview of the clinical use of antibodies in COVID-19.

VACCINES (2021)

Add to Collection

Review Endocrinology & Metabolism

Molnupiravir in COVID-19: A systematic review of literature

Awadhesh Kumar Singh et al.

Summary: Molnupiravir has shown significant benefits in reducing hospitalization or death in mild COVID-19 cases, making it a potential important tool in combating SARSCoV-2. However, its efficacy in moderate to severe COVID-19 remains uncertain, requiring further studies for clarification.

DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2021)

Add to Collection

Article Multidisciplinary Sciences

Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival

Stefania Dispinseri et al.

Summary: The study reveals that antibody responses to SARS-CoV-2 spike protein play a significant role in neutralization and protection against severe COVID-19, unaffected by heterologous boosting or common cold immunity, and can last for up to 8 months.

NATURE COMMUNICATIONS (2021)

Add to Collection

Article Urology & Nephrology

Early Humoral Responses of Hemodialysis Patients after COVID-19 Vaccination with BNT162b2

Claudius Speer et al.

Summary: Patients receiving long-term hemodialysis show a reduced antibody response to the first and second doses of the mRNA vaccine BNT162b2. The majority (82%) develop neutralizing antibodies after the second dose but at lower levels than healthy controls.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)

Add to Collection

Article Urology & Nephrology

Immunogenicity of a first dose of mRNA- or vector-based SARS-CoV-2 vaccination in dialysis patients: a multicenter prospective observational pilot study

Paul Lesny et al.

Summary: Dialysis patients have lower immunogenicity following the first dose of SARS-CoV-2 vaccination compared to peritoneal dialysis patients and healthy staff, as well as compared to dialysis patients with prior COVID-19 infection.

JOURNAL OF NEPHROLOGY (2021)

Add to Collection

Letter Urology & Nephrology

Antibody Response to COVID-19 Vaccination in Patients Receiving Dialysis

Shuchi Anand et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)

Add to Collection

Article Urology & Nephrology

Humoral Response after SARS-CoV-2 mRNA Vaccination in a Cohort of Hemodialysis Patients and Kidney Transplant Recipients

Clement Danthu et al.

Summary: The study shows that kidney transplant recipients have a strong inhibition of humoral response to COVID-19 vaccination due to immunosuppressant therapy, while patients undergoing hemodialysis have lower antibody levels. Factors such as age, serum albumin, and Kt/V can impact the level of antibody response.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)

Add to Collection

Letter Urology & Nephrology

Seroprevalence of antibody to S1 spike protein following vaccination against COVID-19 in patients receiving hemodialysis: a call to arms

Roseanne E. Billany et al.

KIDNEY INTERNATIONAL (2021)

Add to Collection

Letter Medicine, General & Internal

Neutralising antibodies after COVID-19 vaccination in UK haemodialysis patients

Edward J. Carr et al.

LANCET (2021)

Add to Collection

Article Geriatrics & Gerontology

Differential immunogenicity of BNT162b2 or ChAdOx1 vaccines after extended-interval homologous dual vaccination in older people

Helen Parry et al.

Summary: The study analyzed the immune responses of participants aged 80+ years after dual vaccination with BNT162b2 mRNA or ChAdOx1 adenovirus vaccines, showing strong humoral and cellular responses in older individuals. Dual vaccination induced higher antibody responses with the mRNA vaccine and higher cellular responses with the adenovirus-based vaccine, highlighting the potential benefits of heterologous vaccine platforms.

IMMUNITY & AGEING (2021)

Add to Collection

Article Immunology

Neutralizing Antibodies Titers and Side Effects in Response to BNT162b2 Vaccine in Healthcare Workers with and without Prior SARS-CoV-2 Infection

Jose Javier Morales-Nunez et al.

Summary: The study evaluated the efficacy of the Pfizer-BioNTech vaccine in producing neutralizing antibodies, finding 100% production after the second dose in both groups and well-tolerated side effects. Additionally, a single dose of the vaccine may be sufficient for immunity in individuals with prior COVID-19 infection, with possible signs of immunosenescence.

VACCINES (2021)

Add to Collection

Review Immunology

The Efficacy of COVID-19 Vaccines in Chronic Kidney Disease and Kidney Transplantation Patients: A Narrative Review

Yi-Chou Hou et al.

Summary: The SARS-CoV-2 pandemic poses a significant threat to global health, especially for vulnerable populations like those with chronic kidney disease. Vaccination against SARS-CoV-2 may have reduced effectiveness in individuals with CKD, requiring special attention to dosage to ensure vaccine efficacy.

VACCINES (2021)

Add to Collection

Article Health Care Sciences & Services

Prognostic Implication of Longitudinal Changes in Cardiothoracic Ratio and Aortic Arch Calcification in Hemodialysis Patients

Tung-Ling Chung et al.

Summary: In this longitudinal follow-up study of 260 hemodialysis patients from 2008 to 2015, it was found that both CTR and AoAC increased over time and were associated with factors such as age, gender, and comorbidities. The change in CTR was greater in patients who died compared to those who survived, indicating that changes in CTR and AoAC can serve as prognostic markers for patients.

JOURNAL OF PERSONALIZED MEDICINE (2021)

Add to Collection

Article Health Care Sciences & Services

Aortic Arch Calcification and Cardiomegaly Are Associated with Overall and Cardiovascular Mortality in Hemodialysis Patients

Shih-Hsiang Ou et al.

Summary: This study found that high levels of aortic arch calcification and cardiothoracic ratio were associated with increased overall and cardiovascular mortality in hemodialysis patients. Adding these two indicators to the basic model improved the predictive ability for patient mortality risk.

JOURNAL OF PERSONALIZED MEDICINE (2021)

Add to Collection

Article Health Care Sciences & Services

Effective Preventive Strategies to Prevent Secondary Transmission of COVID-19 in Hemodialysis Unit: The First Month of Community Outbreak in Taiwan

Chun-Yu Chen et al.

Summary: Effective preventive measures against COVID-19 were implemented in an HD center in Taiwan, resulting in lower incidence rate compared to national and local estimates, with Keelung having the highest incidence among HD patients. Only one patient in the center got infected with COVID-19 and secondary transmission was contained successfully under the implemented measures.

HEALTHCARE (2021)

Add to Collection

Article Geriatrics & Gerontology

Immunogenicity of single vaccination with BNT162b2 or ChAdOx1 nCoV-19 at 5-6 weeks post vaccine in participants aged 80 years or older: an exploratory analysis

Helen Parry et al.

Summary: This study investigated the antibody and cellular responses of older people after receiving a single dose of Pfizer-BioNTech's BNT162b2 vaccine or Oxford University-AstraZeneca's ChAdOx1 nCoV-19 vaccine. The findings showed that single doses of either vaccine induced humoral immunity in most participants, which was significantly enhanced by previous infection. Cellular responses were weaker, but showed improvement after receiving the ChAdOx1 nCoV-19 vaccine at the 5-6 week timepoint.

LANCET HEALTHY LONGEVITY (2021)

Add to Collection

Article Health Care Sciences & Services

Incidence and Clinical Impacts of COVID-19 Infection in Patients with Hemodialysis: Systematic Review and Meta-Analysis of 396,062 Hemodialysis Patients

Chun-Yu Chen et al.

Summary: A total of 3261 confirmed COVID-19 cases were identified in 29 articles from a pool of 396,062 HD patients. The incidence of COVID-19 in these HD patients was 7.7%, with an overall mortality rate of 22.4%. Reported estimates were higher in non-Asian countries compared to Asian countries. Study quality may affect the reported incidence but not the mortality among studies.

HEALTHCARE (2021)

Add to Collection

Article Medicine, General & Internal

Features of 20133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study

Annemarie B. Docherty et al.

BMJ-BRITISH MEDICAL JOURNAL (2020)

Add to Collection

Article Medicine, General & Internal

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Fei Zhou et al.

LANCET (2020)

Add to Collection

Article Public, Environmental & Occupational Health

Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019-United States, February 12-March 28, 2020

Nancy Chow et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)

Add to Collection

Article Medicine, General & Internal

Epidemiology of Covid-19 in a Long-Term Care Facility in King County, Washington

Temet M. McMichael et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Review Immunology

Role of Immune Dysregulation in Increased Mortality Among a Specific Subset of COVID-19 Patients and Immune-Enhancement Strategies for Combatting Through Nutritional Supplements

Kosagi-Sharaf Rao et al.

FRONTIERS IN IMMUNOLOGY (2020)

Add to Collection

Article Public, Environmental & Occupational Health

Coronavirus Disease 2019 Case Surveillance - United States, January 22-May 30, 2020

Erin K. Stokes et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)

Add to Collection

Article Urology & Nephrology

Epidemiology of COVID-19 in an Urban Dialysis Center

Richard W. Corbett et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)

Add to Collection

Article Medicine, General & Internal

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

Pedro M. Folegatti et al.

LANCET (2020)

Add to Collection

Review Microbiology

Factors That Influence the Immune Response to Vaccination

Petra Zimmermann et al.

CLINICAL MICROBIOLOGY REVIEWS (2019)

Add to Collection

Article Urology & Nephrology

Immune Dysfunction and Risk of Infection in Chronic Kidney Disease

Maaz Syed-Ahmed et al.

ADVANCES IN CHRONIC KIDNEY DISEASE (2019)

Add to Collection

Article Urology & Nephrology

Cardiothoracic Ratio and All-Cause Mortality and Cardiovascular Disease Events in Hemodialysis Patients: The Q-Cohort Study

Ryusuke Yotsueda et al.

AMERICAN JOURNAL OF KIDNEY DISEASES (2017)

Add to Collection

Review Urology & Nephrology

Immune cell dysfunction and inflammation in end-stage renal disease

Michiel G. H. Betjes

NATURE REVIEWS NEPHROLOGY (2013)

Add to Collection

Article Biochemistry & Molecular Biology

B cell-associated immune profiles in patients with end-stage renal disease (ESRD)

Kyoung Woon Kim et al.

EXPERIMENTAL AND MOLECULAR MEDICINE (2012)

Add to Collection

Article Transplantation

Effect of end-stage renal disease on B-lymphocyte subpopulations, IL-7, BAFF and BAFF receptor expression

Madeleine V. Pahl et al.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)

Add to Collection

Article Medicine, General & Internal

Cardiothoracic Ratio, Inflammation, Malnutrition, and Mortality in Diabetes Patients on Maintenance Hemodialysis

Tzung-Hai Yen et al.

AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2009)

Add to Collection

Article Physiology

Cardiothoracic ratio, malnutrition, inflammation, and two-year mortality in non-diabetic patients on maintenance hemodialysis

Kuan-Hsing Chen et al.

KIDNEY & BLOOD PRESSURE RESEARCH (2008)

Add to Collection

Review Urology & Nephrology

Disturbances of acquired immunity in hemodialysis patients

Theodoros Eleftheriadis et al.

SEMINARS IN DIALYSIS (2007)

Add to Collection

© Peeref 2019-2024. All rights reserved.